title: Are the endocrine society's clinical practice guidelines on androgen therapy in women misguided? A commentary-response.
authors.forename: Margaret
authors.initials: M
authors.lastname: Wierman
authors.forename: Rosemary
authors.initials: R
authors.lastname: Basson
authors.forename: Susan
authors.initials: S
authors.lastname: Davis
authors.forename: Sundeep
authors.initials: S
authors.lastname: Khosla
authors.forename: Karen
authors.initials: K
authors.lastname: Miller
authors.forename: William
authors.initials: W
authors.lastname: Rosner
authors.forename: Nanette
authors.initials: N
authors.lastname: Santoro
mesh_terms: D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy; D007989:Libido; D008593:Menopause / Q000187:drug effects; D017410:Practice Guidelines as Topic; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy*; D012955:Societies, Medical; D013739:Testosterone / Q000097:blood / Q000172:deficiency / Q000627:therapeutic use*; D016387:Women's Health
chemical_list: D013739:Testosterone